Still plowing through the Annual Financials. Note 15 - CONSOLIDATED ENTITIES - contains some information which looks more relevant. At 30/6/15 we held 66.3% of Admedus Vaccines at a cost to the Company of $9,500,049. At 30/6/16 we held 72.8% of Admedus Vaccines at a cost to the Company of $13,000,049. Looks like we tipped in $3.5m during the year. I'm afraid it is all a mystery to me.
Ann: HSV-2 Interim Results Announcement-AHZ.AX, page-231
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.15 |
Change
-0.500(3.19%) |
Mkt cap ! $291.2M | |||
| Open | High | Low | Value | Volume |
| $15.75 | $15.75 | $15.00 | $294.3K | 19.33K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1135 | $15.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.35 | 88 | 1 |
View Market Depth
| Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |